D'Orazio & Associates’s Allergan plc AGN Stock Holding History

D'Orazio & Associates’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-14	Closed	-$3K	–	372
2019 Q4	$3K	Hold	14	–	–	﹤0.01%	308
2019 Q3	$2K	Hold	14	–	–	﹤0.01%	323
2019 Q2	$2K	Hold	14	–	–	﹤0.01%	311
2019 Q1	$2K	Hold	14	–	–	﹤0.01%	330
2018 Q4	$2K	Hold	14	–	–	﹤0.01%	278
2018 Q3	$3K	Hold	14	–	–	﹤0.01%	254
2018 Q2	$2K	Hold	14	–	–	﹤0.01%	255
2018 Q1	$2K	Hold	14	–	–	﹤0.01%	269
2017 Q4	$2K	Buy	+14	New	+$2.51K	﹤0.01%	310
2017 Q3	–	Sell	-14	Closed	-$3K	–	340
2017 Q2	$3K	Buy	+14	New	+$3.29K	﹤0.01%	290

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D'Orazio & Associates's AGN Position: Q1 2020 in Review

D'Orazio & Associates sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 14 shares — an estimated $3K sold.

D'Orazio & Associates first reported a position in AGN in Q2 2017 and held it in 10 quarters. The position peaked at $3K in Q4 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

D'Orazio & Associates reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
D'Orazio & Associates sold 14 Allergan plc shares in Q1 2020, an estimated $3K.
D'Orazio & Associates first reported a position in Allergan plc in Q2 2017 and held it in 10 quarters.
D'Orazio & Associates's Allergan plc position peaked at $3K in Q4 2019.
876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on D'Orazio & Associates's 13F filing for Q1 2020, filed 28 Apr 2020.